Biora Therapeutics, Inc. (NASDAQ: BIOR) reported Q2 EPS of ($0.03), $0.09 better than the analyst estimate of ($0.12).

For earnings history and earnings-related data on Biora Therapeutics, Inc. (BIOR) click here.